Tilray Inc (NASDAQ:TLRY) gapped up before the market opened on Thursday . The stock had previously closed at $163.20, but opened at $139.60. Tilray shares last traded at $123.24, with a volume of 134481 shares.
Several equities research analysts have recently commented on TLRY shares. Zacks Investment Research upgraded shares of Tilray from a “sell” rating to a “hold” rating in a research note on Wednesday. Roth Capital started coverage on shares of Tilray in a research note on Tuesday, August 14th. They set a “buy” rating and a $35.00 price objective for the company. Cowen lifted their price objective on shares of Tilray from $62.00 to $172.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 9th. Benchmark started coverage on shares of Tilray in a research note on Tuesday, October 16th. They set a “buy” rating and a $200.00 price objective for the company. Finally, Northland Securities downgraded shares of Tilray from an “outperform” rating to a “market perform” rating in a research note on Thursday, September 6th. Three equities research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $135.67.
The company has a quick ratio of 0.51, a current ratio of 0.62 and a debt-to-equity ratio of 0.24.
Tilray (NASDAQ:TLRY) last posted its quarterly earnings data on Tuesday, August 28th. The company reported ($0.17) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.09) by ($0.08). The firm had revenue of $9.70 million for the quarter, compared to analyst estimates of $9.01 million. Tilray’s quarterly revenue was up 94.0% compared to the same quarter last year. On average, analysts anticipate that Tilray Inc will post -0.48 earnings per share for the current year.
Hedge funds and other institutional investors have recently bought and sold shares of the stock. IFP Advisors Inc acquired a new position in Tilray during the third quarter valued at $154,000. G&S Capital LLC acquired a new position in Tilray during the third quarter valued at $155,000. Stratos Wealth Partners LTD. acquired a new position in Tilray during the third quarter valued at $221,000. Oppenheimer & Co. Inc. acquired a new position in Tilray during the third quarter valued at $242,000. Finally, CIBC World Markets Inc. acquired a new position in Tilray during the third quarter valued at $298,000. Institutional investors own 0.04% of the company’s stock.
About Tilray (NASDAQ:TLRY)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
Read More: Reverse Stock Split
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.